NCT02968810 2026-03-18
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
103 trialsNCT07469319 2026-03-13
BISHOP
University of Aarhus
Phase NA Recruiting
NCT05095714 2026-03-12
FASTRAK
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting
NCT03520660 2026-03-11
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
Phase 4 Active not recruiting
NCT06096779 2026-03-06
Kirros
Genentech, Inc.
Phase 2 Recruiting
NCT07010315 2026-03-04
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
M.D. Anderson Cancer Center
Recruiting
NCT04485286 2026-02-27
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
Massachusetts General Hospital
Phase 2 Recruiting
NCT06624189 2026-02-27
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
NYU Langone Health
Enrolling by invitation
NCT04690972 2026-02-12
LivMOD
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
NCT07368309 2026-01-26
Clinical Management Strategies for Patients With Cirrhosis and Esophagogastric Varices Complicated by Early-stage Upper Gastrointestinal Cancer
Renmin Hospital of Wuhan University
Completed
NCT03654053 2026-01-07
SACRED
VA Office of Research and Development
Phase 3 Active not recruiting
NCT04306939 2026-01-07
GREAT1
University of Pittsburgh
Suspended
NCT00243633 2025-12-23
Characterization of Focal Liver Lesions by Real-time Contrast-enhanced Ultrasound Imaging (CEUS)
University Hospital, Tours
Phase NA Completed
NCT03071458 2025-12-10
MUTHEC
Institut National de la Santé Et de la Recherche Médicale, France
Completed
NCT05064553 2025-10-15
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Exact Sciences Corporation
Active not recruiting
NCT02626312 2025-10-14
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT06007846 2025-09-30
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Inova Health Care Services
Phase 2/3 Recruiting
NCT05486572 2025-09-26
PREMIUM
VA Office of Research and Development
Phase NA Recruiting
NCT06265272 2025-09-26
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
Massachusetts General Hospital
Recruiting
NCT05971108 2025-09-24
REVISE-HCC
Manchester University NHS Foundation Trust
Phase NA Recruiting
NCT06658782 2025-09-22
AMULET
University of Oxford
Recruiting
NCT07185360 2025-09-22
LIVER-TRACK
Assistance Publique - Hôpitaux de Paris
Phase NA Not yet recruiting
NCT07132515 2025-08-20
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Mansoura University
Phase 4 Recruiting
NCT05433467 2025-08-13
CTMH
Northern Jiangsu People's Hospital
Phase NA Recruiting
NCT05463796 2025-08-07
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Dana-Farber Cancer Institute
Recruiting
NCT07079150 2025-07-22
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
First Affiliated Hospital Xi'an Jiaotong University
Recruiting
NCT07036874 2025-06-29
Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma
Chinese University of Hong Kong
Recruiting
NCT07042919 2025-06-29
Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
Northwestern University
Phase 1/2 Not yet recruiting
NCT03534141 2025-05-16
MHALT
University of California, San Francisco
Phase NA Terminated
NCT05178303 2025-05-16
SB-1121
Trieu, Nguyen Thi, M.D.
Phase 4 Completed
NCT05201404 2025-04-29
LIVERATION
Can-Fite BioPharma
Phase 3 Recruiting
NCT03507140 2025-04-20
BIM-LT
University Hospital, Grenoble
Completed
NCT02908048 2025-04-06
Extracellular RNA Markers of Liver Disease and Cancer
Mayo Clinic
Active not recruiting
NCT05586516 2025-03-20
A Study to Assess an ATX Inhibitor (IOA-289) in Patients with Metastatic Pancreatic Cancer
iOnctura
Phase 1/2 Active not recruiting
NCT06864195 2025-03-07
VOCAL2
Imperial College London
Recruiting
NCT05683548 2025-02-17
RCAP
Replicor Inc.
No longer available
NCT06778317 2025-01-20
SEPT9_SuRV
Central Hospital, Nancy, France
Not yet recruiting
NCT03311152 2025-01-14
SEPT9-CROSS
Central Hospital, Nancy, France
Phase NA Completed
NCT04179773 2025-01-14
CHIMIOSE
University Hospital, Lille
Terminated
NCT04802954 2024-12-18
STARHE
IHU Strasbourg
Phase NA Completed
NCT06683820 2024-12-05
Triple Recipient Strategy Using Split, Domino, and Auxiliary Techniques
Second Affiliated Hospital, School of Medicine, Zhejiang University
Completed
NCT02143401 2024-11-22
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT05027425 2024-11-22
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Phase 2 Active not recruiting
NCT00059267 2024-11-15
Prevention of Recurrent Hepatitis B After Liver Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed
NCT06420791 2024-05-20
The Dual Impact of Cirrhosis on Transplantation for Hepatocellular Carcinoma：a Two-center Retrospective Cohort Study in China
Zhejiang University
Completed
NCT02273362 2024-03-26
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT06315361 2024-03-18
DIANA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Active not recruiting
NCT05429190 2023-11-29
Validation of SMS Protocol for HCC Screening in High-risk Patients
Erasmus Medical Center
Enrolling by invitation
NCT04620538 2023-10-10
VOCAL
Imperial College London
Unknown
NCT04248816 2023-02-14
Hepatocellular Carcinoma Surveillance in Cirrhotics
University of Pennsylvania
Phase NA Completed